Showing results (41-50 of 599) with videos related to
Sort By:
Pageof 60
AMA Journal of Ethics|August 30, 2021
How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care?Sahan Jayawardana, Elias MossialosBulletin of the World Health Organization|May 4, 2005
Advance price or purchase commitments to create markets for treatments for diseases of poverty: lessons from three policiesAdrian Towse, Hannah KettlerInternational Journal of Technology Assessment in Health Care|December 3, 2013
Approaches to identifying, measuring, and aggregating elements of valueAdrian Towse, Paul BarnsleyNpj Antimicrobials and Resistance|January 22, 2025
Policy options for sustainable access to off-patent antibiotics in EuropeDimitra Panteli, Michael Anderson, Thomas Fieldman, et al.Globalization and Health|March 23, 2016
A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facilityDavid M Brogan, Elias MossialosHealth Policy (Amsterdam, Netherlands)|March 20, 2003
Stimulating pharmaceutical research and development for neglected diseasesMonique F Mrazek, Elias MossialosHealth Affairs (Project Hope)|September 8, 2010
Fighting antibiotic resistance: marrying new financial incentives to meeting public health goalsAaron S Kesselheim, Kevin OuttersonHealth Affairs (Project Hope)|May 4, 2016
Cancer Drugs Provide Positive Value In Nine Countries, But The United States Lags In Health Gains Per Dollar SpentSebastian Salas-Vega, Elias MossialosSocial Science & Medicine (1982)|January 26, 2016
Systems, not pills: The options market for antibiotics seeks to rejuvenate the antibiotic pipelineDavid M Brogan, Elias MossialosGlobalization and Health|November 9, 2013
Incentives for new antibiotics: the Options Market for Antibiotics (OMA) modelDavid M Brogan, Elias MossialosPageof 60